Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAberdeen Uk Sm. Regulatory News (AUSC)

Share Price Information for Aberdeen Uk Sm. (AUSC)

Share Price is delayed by 15 minutes
Get Live Data
496.00    2.00 (0.40%)
Bid:
493.50
Ask:
497.50
Spread: 4.00 (0.811%)
Market Cap: £228.72m
AUSC Live PriceLast checked at - London Stock Exchange

Intraday Aberdeen Uk Sm. Share Chart

Amendment to Management Fee

3 Apr 2025 07:00

RNS Number : 4110D
abrdn UK Smaller Cos. Growth Trust
03 April 2025
 

3 April 2025

 

abrdn UK Smaller Companies Growth Trust plc

Legal Entity Identifier (LEI): 213800UUKA68SHSJBE37

 

 

Amendment to Management Fee

 

The Board of abrdn UK Smaller Companies Growth Trust plc (the "Company") is pleased to announce that it has agreed a change to the terms of the management fee payable by the Company to Aberdeen Investments ("Aberdeen").

 

With effect from 1 April 2025, the Company's management fee will continue to be charged on a tiered basis, but at reduced rates of 0.60% per annum on the first £200 million of the Net Asset Value ("NAV") and 0.55% on NAV above this figure.

 

Prior to 1 April 2025, the Company's management fee was charged at a rate of 0.75% per annum of the NAV up to £175 million, 0.65% above £175 million and below £550 million, and 0.55% above £550 million.

 

Save for this change, all other terms and conditions contained in the Company's Management Agreement remain unchanged.

 

Liz Airey, Chairman of the Company commented "The Board is pleased to announce this change in the management fee with Aberdeen. We believe that this arrangement will reduce the cost of managing the portfolio by approximately 17.5% per annum to the benefit of all shareholders. As this change is being implemented with only three months of the current financial year left to run, the impact will be more limited in the year to 30 June 2025. However, had the new management fee arrangement been in place for the whole of the financial year to 30 June 2024, then the ongoing charges ratio ("OCR") would have been around 0.80%, rather than the reported 0.92%. The Board considers that this revised fee structure makes the Company more competitive.

 

 

For further information, please contact:

 

G Hay Smith

abrdn Holdings Limited

Company Secretary

0131 372 9370

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFZGGDKZKGKZM
Date   Source Headline
13th Jan 20255:09 pmRNSTransaction in Own Shares
13th Jan 20251:00 pmRNSGearing disclosure
13th Jan 202512:03 pmRNSNet Asset Value(s)
10th Jan 20255:09 pmRNSTransaction in Own Shares
10th Jan 20255:04 pmRNSPortfolio disclosure
10th Jan 202511:22 amRNSNet Asset Value(s)
9th Jan 20255:17 pmRNSTransaction in Own Shares
9th Jan 202512:19 pmRNSNet Asset Value(s)
8th Jan 20255:08 pmRNSTransaction in Own Shares
8th Jan 202512:42 pmRNSNet Asset Value(s)
7th Jan 20255:23 pmRNSTransaction in Own Shares
7th Jan 20254:24 pmRNSDirector Declaration
7th Jan 20252:58 pmRNSMonth End Net Asset Value(s)
7th Jan 202511:50 amRNSNet Asset Value(s)
6th Jan 20255:14 pmRNSTransaction in Own Shares
6th Jan 20252:06 pmRNSGearing disclosure
6th Jan 202511:37 amRNSNet Asset Value(s)
3rd Jan 20255:21 pmRNSTransaction in Own Shares
3rd Jan 20254:22 pmRNSQuarterly disclosure
3rd Jan 202512:47 pmRNSNet Asset Value(s)
2nd Jan 20255:14 pmRNSTransaction in Own Shares
2nd Jan 202510:23 amRNSTotal Voting Rights
31st Dec 20241:18 pmRNSTransaction in Own Shares
31st Dec 202412:48 pmRNSNet Asset Value(s)
30th Dec 20245:26 pmRNSTransaction in Own Shares
30th Dec 20241:48 pmRNSGearing disclosure
30th Dec 20241:01 pmRNSNet Asset Value(s)
27th Dec 20245:11 pmRNSTransaction in Own Shares
27th Dec 202412:31 pmRNSNet Asset Value(s)
24th Dec 20241:27 pmRNSTransaction in Own Shares
24th Dec 202412:41 pmRNSNet Asset Value(s)
23rd Dec 20245:16 pmRNSTransaction in Own Shares
23rd Dec 20241:10 pmRNSGearing disclosure
23rd Dec 202412:49 pmRNSNet Asset Value(s)
20th Dec 20245:10 pmRNSTransaction in Own Shares
20th Dec 20241:14 pmRNSNet Asset Value(s)
19th Dec 202412:33 pmRNSNet Asset Value(s)
18th Dec 20245:25 pmRNSTransaction in Own Shares
18th Dec 202411:58 amRNSNet Asset Value(s)
17th Dec 20245:14 pmRNSTransaction in Own Shares
17th Dec 202411:55 amRNSNet Asset Value(s)
16th Dec 20245:12 pmRNSTransaction in Own Shares
16th Dec 20243:09 pmRNSGearing disclosure
16th Dec 202412:56 pmRNSNet Asset Value(s)
13th Dec 20245:19 pmRNSTransaction in Own Shares
13th Dec 202412:16 pmRNSNet Asset Value(s)
12th Dec 20245:06 pmRNSTransaction in Own Shares
12th Dec 202412:04 pmRNSNet Asset Value(s)
11th Dec 20245:23 pmRNSPortfolio Disclosures
11th Dec 202412:34 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.